Prevalence of hyperlipidemia in psoriatic arthritis patients in Riyadh, Saudi Arabia
To estimate the prevalence of hyperlipidemia in patients with psoriatic arthritis (PsA) in Riyadh, Saudi Arabia, and to investigate the relationship between PsA and hyperlipidemia. This retrospective study examined medical records of PsA patients from January 2010 to May 2023 at 2 medical centers in...
Gespeichert in:
| Veröffentlicht in: | Saudi medical journal 2024-12, Vol.45 (12), p.1340-1346 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1346 |
|---|---|
| container_issue | 12 |
| container_start_page | 1340 |
| container_title | Saudi medical journal |
| container_volume | 45 |
| creator | AlTalhi, Khalid Alotaiwi, Sara Alotaibi, Mohammed Alhamzi, Hanan A Alrashedi, Seham Makkawy, Mosaab Alokaily, Fahdah |
| description | To estimate the prevalence of hyperlipidemia in patients with psoriatic arthritis (PsA) in Riyadh, Saudi Arabia, and to investigate the relationship between PsA and hyperlipidemia.
This retrospective study examined medical records of PsA patients from January 2010 to May 2023 at 2 medical centers in Riyadh. Patients over 18 years old with a lipid profile were included. Hyperlipidemia cases were determined using Adult Treatment Panel III (ATP III) guidelines and European Association of Preventive Cardiology definitions based on lipid profile results.
A total of 141 patients were included in the analysis. The prevalence of hyperlipidemia in patients with PsA was 40.7% at diagnosis, and 28.7% at the last visit. The prevalence of hyperlipidemia was significantly higher in males than females (56% versus [vs] 29.4%, |
| doi_str_mv | 10.15537/smj.2024.45.12.20240817 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11629641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A820021100</galeid><sourcerecordid>A820021100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2787-8baa4ffdb0987d54bf117aa4b6787de8087b29f3257b8eca682ca1a46064ca783</originalsourceid><addsrcrecordid>eNptUV1rFDEUDaLYdfUvSMBXZ8zNJJPMkyxFrVBQtD6HO5mke8vOB8m2sP_ebLctFiQPSe6553DvOYxxEDVo3ZhPebyppZCqVroGef8UFswLtoJW26oBo1-ylWhMV2lp1Rl7k_ONEE3bivY1O2u60gUgV-zqZwp3uAuTD3yOfHtYQtrRQkMYCTlNfMlzItyT55j220R7ynwp_zDt8xH_RQccth_5b7wdiG8S9oRv2auIuxzePdxr9ufrl6vzi-ryx7fv55vLyktjTWV7RBXj0IvOmkGrPgKYUurbgg7BCmt62cVGatPb4LG10iOgKjsoj8Y2a_b5pLvc9mMYfJkp4c4tiUZMBzcjuefIRFt3Pd85gFZ2rYKi8OGkcF08cDTFufT5kbJ3GyuFkADFtTWr_9NVztElP08hUqk_I9gTwac55xTi00wg3H2CriTojrE5pR1I95hgob7_d6cn4mNkzV-MPJih</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prevalence of hyperlipidemia in psoriatic arthritis patients in Riyadh, Saudi Arabia</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>AlTalhi, Khalid ; Alotaiwi, Sara ; Alotaibi, Mohammed ; Alhamzi, Hanan A ; Alrashedi, Seham ; Makkawy, Mosaab ; Alokaily, Fahdah</creator><creatorcontrib>AlTalhi, Khalid ; Alotaiwi, Sara ; Alotaibi, Mohammed ; Alhamzi, Hanan A ; Alrashedi, Seham ; Makkawy, Mosaab ; Alokaily, Fahdah</creatorcontrib><description>To estimate the prevalence of hyperlipidemia in patients with psoriatic arthritis (PsA) in Riyadh, Saudi Arabia, and to investigate the relationship between PsA and hyperlipidemia.
This retrospective study examined medical records of PsA patients from January 2010 to May 2023 at 2 medical centers in Riyadh. Patients over 18 years old with a lipid profile were included. Hyperlipidemia cases were determined using Adult Treatment Panel III (ATP III) guidelines and European Association of Preventive Cardiology definitions based on lipid profile results.
A total of 141 patients were included in the analysis. The prevalence of hyperlipidemia in patients with PsA was 40.7% at diagnosis, and 28.7% at the last visit. The prevalence of hyperlipidemia was significantly higher in males than females (56% versus [vs] 29.4%,
<0.005). While not statistically significant, among patients who received a biologic disease-modifying antirheumatic drugs (bDMARD), 31.6% had hyperlipidemia at the last visit, compared to 20% of those who did not receive it (
=0.317). Among patients who received conventional disease-modifying antirheumatic drugs (cDMARD), 30% had hyperlipidemia at the last visit, compared to 25.8% of those who did not it (
=0.813). The prevalence rates of hyperlipidemia at the first visit and the last visit were found to be statistically significant among patients who have comorbidities other than PsA (7.6 vs. 17.3%,
=0.004).
The study results are comparable to those of other studies showing no significant effect of PsA on the lipid profile. The prevalence of hyperlipidemia in PsA patients appears similar to that of the general population in Saudi Arabia, based on indirect comparison.</description><identifier>ISSN: 0379-5284</identifier><identifier>EISSN: 1658-3175</identifier><identifier>DOI: 10.15537/smj.2024.45.12.20240817</identifier><identifier>PMID: 39658112</identifier><language>eng</language><publisher>Saudi Arabia: Saudi Medical Journal</publisher><subject>Adult ; Antilipemic agents ; Antirheumatic agents ; Antirheumatic Agents - therapeutic use ; Arthritis, Psoriatic - epidemiology ; Cardiology ; Comorbidity ; Complications and side effects ; Female ; Humans ; Hyperlipidemia ; Hyperlipidemias - epidemiology ; Male ; Medical centers ; Medical research ; Medicine, Experimental ; Middle Aged ; Original ; Prevalence ; Psoriatic arthritis ; Retrospective Studies ; Risk factors ; Saudi Arabia - epidemiology ; Statistics ; Type 2 diabetes</subject><ispartof>Saudi medical journal, 2024-12, Vol.45 (12), p.1340-1346</ispartof><rights>Copyright: © Saudi Medical Journal.</rights><rights>COPYRIGHT 2024 Saudi Medical Journal</rights><rights>Copyright: © Saudi Medical Journal 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-0878-0200</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11629641/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11629641/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39658112$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AlTalhi, Khalid</creatorcontrib><creatorcontrib>Alotaiwi, Sara</creatorcontrib><creatorcontrib>Alotaibi, Mohammed</creatorcontrib><creatorcontrib>Alhamzi, Hanan A</creatorcontrib><creatorcontrib>Alrashedi, Seham</creatorcontrib><creatorcontrib>Makkawy, Mosaab</creatorcontrib><creatorcontrib>Alokaily, Fahdah</creatorcontrib><title>Prevalence of hyperlipidemia in psoriatic arthritis patients in Riyadh, Saudi Arabia</title><title>Saudi medical journal</title><addtitle>Saudi Med J</addtitle><description>To estimate the prevalence of hyperlipidemia in patients with psoriatic arthritis (PsA) in Riyadh, Saudi Arabia, and to investigate the relationship between PsA and hyperlipidemia.
This retrospective study examined medical records of PsA patients from January 2010 to May 2023 at 2 medical centers in Riyadh. Patients over 18 years old with a lipid profile were included. Hyperlipidemia cases were determined using Adult Treatment Panel III (ATP III) guidelines and European Association of Preventive Cardiology definitions based on lipid profile results.
A total of 141 patients were included in the analysis. The prevalence of hyperlipidemia in patients with PsA was 40.7% at diagnosis, and 28.7% at the last visit. The prevalence of hyperlipidemia was significantly higher in males than females (56% versus [vs] 29.4%,
<0.005). While not statistically significant, among patients who received a biologic disease-modifying antirheumatic drugs (bDMARD), 31.6% had hyperlipidemia at the last visit, compared to 20% of those who did not receive it (
=0.317). Among patients who received conventional disease-modifying antirheumatic drugs (cDMARD), 30% had hyperlipidemia at the last visit, compared to 25.8% of those who did not it (
=0.813). The prevalence rates of hyperlipidemia at the first visit and the last visit were found to be statistically significant among patients who have comorbidities other than PsA (7.6 vs. 17.3%,
=0.004).
The study results are comparable to those of other studies showing no significant effect of PsA on the lipid profile. The prevalence of hyperlipidemia in PsA patients appears similar to that of the general population in Saudi Arabia, based on indirect comparison.</description><subject>Adult</subject><subject>Antilipemic agents</subject><subject>Antirheumatic agents</subject><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Psoriatic - epidemiology</subject><subject>Cardiology</subject><subject>Comorbidity</subject><subject>Complications and side effects</subject><subject>Female</subject><subject>Humans</subject><subject>Hyperlipidemia</subject><subject>Hyperlipidemias - epidemiology</subject><subject>Male</subject><subject>Medical centers</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Prevalence</subject><subject>Psoriatic arthritis</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Saudi Arabia - epidemiology</subject><subject>Statistics</subject><subject>Type 2 diabetes</subject><issn>0379-5284</issn><issn>1658-3175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptUV1rFDEUDaLYdfUvSMBXZ8zNJJPMkyxFrVBQtD6HO5mke8vOB8m2sP_ebLctFiQPSe6553DvOYxxEDVo3ZhPebyppZCqVroGef8UFswLtoJW26oBo1-ylWhMV2lp1Rl7k_ONEE3bivY1O2u60gUgV-zqZwp3uAuTD3yOfHtYQtrRQkMYCTlNfMlzItyT55j220R7ynwp_zDt8xH_RQccth_5b7wdiG8S9oRv2auIuxzePdxr9ufrl6vzi-ryx7fv55vLyktjTWV7RBXj0IvOmkGrPgKYUurbgg7BCmt62cVGatPb4LG10iOgKjsoj8Y2a_b5pLvc9mMYfJkp4c4tiUZMBzcjuefIRFt3Pd85gFZ2rYKi8OGkcF08cDTFufT5kbJ3GyuFkADFtTWr_9NVztElP08hUqk_I9gTwac55xTi00wg3H2CriTojrE5pR1I95hgob7_d6cn4mNkzV-MPJih</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>AlTalhi, Khalid</creator><creator>Alotaiwi, Sara</creator><creator>Alotaibi, Mohammed</creator><creator>Alhamzi, Hanan A</creator><creator>Alrashedi, Seham</creator><creator>Makkawy, Mosaab</creator><creator>Alokaily, Fahdah</creator><general>Saudi Medical Journal</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0878-0200</orcidid></search><sort><creationdate>202412</creationdate><title>Prevalence of hyperlipidemia in psoriatic arthritis patients in Riyadh, Saudi Arabia</title><author>AlTalhi, Khalid ; Alotaiwi, Sara ; Alotaibi, Mohammed ; Alhamzi, Hanan A ; Alrashedi, Seham ; Makkawy, Mosaab ; Alokaily, Fahdah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2787-8baa4ffdb0987d54bf117aa4b6787de8087b29f3257b8eca682ca1a46064ca783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Antilipemic agents</topic><topic>Antirheumatic agents</topic><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Psoriatic - epidemiology</topic><topic>Cardiology</topic><topic>Comorbidity</topic><topic>Complications and side effects</topic><topic>Female</topic><topic>Humans</topic><topic>Hyperlipidemia</topic><topic>Hyperlipidemias - epidemiology</topic><topic>Male</topic><topic>Medical centers</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Prevalence</topic><topic>Psoriatic arthritis</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Saudi Arabia - epidemiology</topic><topic>Statistics</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AlTalhi, Khalid</creatorcontrib><creatorcontrib>Alotaiwi, Sara</creatorcontrib><creatorcontrib>Alotaibi, Mohammed</creatorcontrib><creatorcontrib>Alhamzi, Hanan A</creatorcontrib><creatorcontrib>Alrashedi, Seham</creatorcontrib><creatorcontrib>Makkawy, Mosaab</creatorcontrib><creatorcontrib>Alokaily, Fahdah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Saudi medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AlTalhi, Khalid</au><au>Alotaiwi, Sara</au><au>Alotaibi, Mohammed</au><au>Alhamzi, Hanan A</au><au>Alrashedi, Seham</au><au>Makkawy, Mosaab</au><au>Alokaily, Fahdah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of hyperlipidemia in psoriatic arthritis patients in Riyadh, Saudi Arabia</atitle><jtitle>Saudi medical journal</jtitle><addtitle>Saudi Med J</addtitle><date>2024-12</date><risdate>2024</risdate><volume>45</volume><issue>12</issue><spage>1340</spage><epage>1346</epage><pages>1340-1346</pages><issn>0379-5284</issn><eissn>1658-3175</eissn><abstract>To estimate the prevalence of hyperlipidemia in patients with psoriatic arthritis (PsA) in Riyadh, Saudi Arabia, and to investigate the relationship between PsA and hyperlipidemia.
This retrospective study examined medical records of PsA patients from January 2010 to May 2023 at 2 medical centers in Riyadh. Patients over 18 years old with a lipid profile were included. Hyperlipidemia cases were determined using Adult Treatment Panel III (ATP III) guidelines and European Association of Preventive Cardiology definitions based on lipid profile results.
A total of 141 patients were included in the analysis. The prevalence of hyperlipidemia in patients with PsA was 40.7% at diagnosis, and 28.7% at the last visit. The prevalence of hyperlipidemia was significantly higher in males than females (56% versus [vs] 29.4%,
<0.005). While not statistically significant, among patients who received a biologic disease-modifying antirheumatic drugs (bDMARD), 31.6% had hyperlipidemia at the last visit, compared to 20% of those who did not receive it (
=0.317). Among patients who received conventional disease-modifying antirheumatic drugs (cDMARD), 30% had hyperlipidemia at the last visit, compared to 25.8% of those who did not it (
=0.813). The prevalence rates of hyperlipidemia at the first visit and the last visit were found to be statistically significant among patients who have comorbidities other than PsA (7.6 vs. 17.3%,
=0.004).
The study results are comparable to those of other studies showing no significant effect of PsA on the lipid profile. The prevalence of hyperlipidemia in PsA patients appears similar to that of the general population in Saudi Arabia, based on indirect comparison.</abstract><cop>Saudi Arabia</cop><pub>Saudi Medical Journal</pub><pmid>39658112</pmid><doi>10.15537/smj.2024.45.12.20240817</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-0878-0200</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0379-5284 |
| ispartof | Saudi medical journal, 2024-12, Vol.45 (12), p.1340-1346 |
| issn | 0379-5284 1658-3175 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11629641 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
| subjects | Adult Antilipemic agents Antirheumatic agents Antirheumatic Agents - therapeutic use Arthritis, Psoriatic - epidemiology Cardiology Comorbidity Complications and side effects Female Humans Hyperlipidemia Hyperlipidemias - epidemiology Male Medical centers Medical research Medicine, Experimental Middle Aged Original Prevalence Psoriatic arthritis Retrospective Studies Risk factors Saudi Arabia - epidemiology Statistics Type 2 diabetes |
| title | Prevalence of hyperlipidemia in psoriatic arthritis patients in Riyadh, Saudi Arabia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T06%3A26%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20hyperlipidemia%20in%20psoriatic%20arthritis%20patients%20in%20Riyadh,%20Saudi%20Arabia&rft.jtitle=Saudi%20medical%20journal&rft.au=AlTalhi,%20Khalid&rft.date=2024-12&rft.volume=45&rft.issue=12&rft.spage=1340&rft.epage=1346&rft.pages=1340-1346&rft.issn=0379-5284&rft.eissn=1658-3175&rft_id=info:doi/10.15537/smj.2024.45.12.20240817&rft_dat=%3Cgale_pubme%3EA820021100%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/39658112&rft_galeid=A820021100&rfr_iscdi=true |